E. Cohen

852 total citations
19 papers, 632 citations indexed

About

E. Cohen is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, E. Cohen has authored 19 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 10 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in E. Cohen's work include Hepatitis C virus research (14 papers), Liver Disease Diagnosis and Treatment (7 papers) and HIV/AIDS drug development and treatment (6 papers). E. Cohen is often cited by papers focused on Hepatitis C virus research (14 papers), Liver Disease Diagnosis and Treatment (7 papers) and HIV/AIDS drug development and treatment (6 papers). E. Cohen collaborates with scholars based in United States, United Kingdom and Germany. E. Cohen's co-authors include Eric Lawitz, Daniel E. Cohen, Michael Bennett, Manal Abunimeh, Parvez Mantry, K. Rajender Reddy, Amit Khatri, Nancy S. Shulman, Paul J. Pockros and David Bernstein and has published in prestigious journals such as Gastroenterology, Cell Metabolism and Journal of Hepatology.

In The Last Decade

E. Cohen

19 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Cohen United States 10 400 364 135 116 97 19 632
Tajana Filipec Kanižaj Croatia 12 140 0.3× 202 0.6× 175 1.3× 43 0.4× 26 0.3× 45 381
Donald E. Wheeler United States 9 134 0.3× 198 0.5× 68 0.5× 49 0.4× 19 0.2× 11 319
Bülent Değertekın Türkiye 12 336 0.8× 411 1.1× 54 0.4× 33 0.3× 71 0.7× 25 519
Şule Poturoğlu Türkiye 11 134 0.3× 239 0.7× 79 0.6× 41 0.4× 29 0.3× 30 378
Viola Knop Germany 12 345 0.9× 377 1.0× 46 0.3× 8 0.1× 45 0.5× 20 504
Chuanmin Wang Australia 17 214 0.5× 99 0.3× 393 2.9× 9 0.1× 45 0.5× 45 909
Klaus‐Dieter Palitzsch Germany 9 100 0.3× 126 0.3× 74 0.5× 44 0.4× 15 0.2× 18 353
Yingfeng Wei China 14 56 0.1× 160 0.4× 43 0.3× 12 0.1× 68 0.7× 20 485
Jeysen Yogaratnam United States 10 172 0.4× 211 0.6× 26 0.2× 53 0.5× 39 0.4× 22 342
Kunihide Ishii Japan 11 154 0.4× 202 0.6× 40 0.3× 17 0.1× 23 0.2× 33 530

Countries citing papers authored by E. Cohen

Since Specialization
Citations

This map shows the geographic impact of E. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Cohen more than expected).

Fields of papers citing papers by E. Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Cohen. The network helps show where E. Cohen may publish in the future.

Co-authorship network of co-authors of E. Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of E. Cohen. A scholar is included among the top collaborators of E. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Cohen. E. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Lawitz, Eric, Edward Gane, E. Cohen, et al.. (2018). Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney Disease. Kidney International Reports. 4(2). 257–266. 17 indexed citations
4.
5.
Poordad, Fred, David R. Nelson, Jordan J. Feld, et al.. (2017). Safety of the 2D/3D direct-acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis – A pooled analysis. Journal of Hepatology. 67(4). 700–707. 7 indexed citations
6.
Pockros, Paul J., K. Rajender Reddy, Parvez Mantry, et al.. (2016). Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease. Gastroenterology. 150(7). 1590–1598. 197 indexed citations
7.
Poordad, F., Michael Bennett, Thomas Sepe, et al.. (2016). Ombitasvir/Paritaprevir/R, Dasabuvir, and Sofosbuvir Treatment of Patients with HCV Genotype-Infection who Failed a Prior Course of DAA Therapy: The Quartz-I Study. Journal of Hepatology. 64(2). S767–S768. 18 indexed citations
8.
Forns, Xavier, Tania M. Welzel, E. Cohen, et al.. (2016). Sustained Virologic Response Predicts Fibrosis Regression Measured by Fibrotest in HCV-Infected Patients. Journal of Hepatology. 64(2). S829–S830. 1 indexed citations
9.
Shafran, Stephen, David Shaw, Kosh Agarwal, et al.. (2016). QUARTZ II-III: Final Efficacy and Safety Results in Patients with HCV Genotype 2 or 3 Infection Treated With Ombitasvir/Paritaprevir/Ritonavir and Sofosbuvir With or Without Ribavirin. Queen Mary Research Online (Queen Mary University of London). 1 indexed citations
10.
Poordad, Fred, Michael Bennett, Thomas Sepe, et al.. (2016). 604 Ombitasvir/Paritaprevir/r, Dasabuvir, and Sofosbuvir Treatment of Patients With HCV Genotype 1-Infection Who Failed a Prior Course of DAA Therapy: The QUARTZ-I Study. Gastroenterology. 150(4). S1040–S1040. 4 indexed citations
11.
12.
Pockros, Paul J., K. Rajender Reddy, Parvez Mantry, et al.. (2015). LO1 : Safety of ombitasvir/paritaprevir/ritonavir plus dasabuvir for treating HCV GT1 infection in patients with severe renal impairment or end-stage renal disease: The RUBY-I study. Journal of Hepatology. 62. S257–S257. 60 indexed citations
13.
Smith, Eric P., Zhibo An, Alfor G. Lewis, et al.. (2014). The Role of β Cell Glucagon-like Peptide-1 Signaling in Glucose Regulation and Response to Diabetes Drugs. Cell Metabolism. 19(6). 1050–1057. 139 indexed citations
14.
15.
Cohen, E., et al.. (2014). Acute Pediatric Leg Compartment Syndrome in Chronic Myeloid Leukemia. Orthopedics. 37(11). e1036–9. 5 indexed citations
16.
Tapper, Elliot B., E. Cohen, Keyur Patel, et al.. (2012). Levels of Alanine Aminotransferase Confound Use of Transient Elastography to Diagnose Fibrosis in Patients With Chronic Hepatitis C Virus Infection. Clinical Gastroenterology and Hepatology. 10(8). 932–937.e1. 74 indexed citations
17.
Cohen, E., Philipp J. Hohensinner, Christoph Kaun, et al.. (2006). Statins decrease TNF-α-induced osteoprotegerin production by endothelial cells and smooth muscle cells in vitro. Biochemical Pharmacology. 73(1). 77–83. 34 indexed citations
18.
Cohen, E., et al.. (1997). Benchmarking: a management tool for academic medical centers.. PubMed. 1(2). 57–61. 1 indexed citations
19.
Westerhof, W., C.J.W. van Ginkel, E. Cohen, & Jan R. Mekkes. (1990). Prospective Randomized Study Comparing the Debriding Effect of Krill Enzymes and a Non-Enzymatic Treatment in Venous Leg Ulcers. Dermatology. 181(4). 293–297. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tajana Filipec Kanižaj Breakdown of academic impact, for papers by Donald E. Wheeler Breakdown of academic impact, for papers by Bülent Değertekın Breakdown of academic impact, for papers by Şule Poturoğlu Breakdown of academic impact, for papers by Viola Knop Breakdown of academic impact, for papers by Chuanmin Wang Breakdown of academic impact, for papers by Klaus‐Dieter Palitzsch Breakdown of academic impact, for papers by Yingfeng Wei Breakdown of academic impact, for papers by Jeysen Yogaratnam Breakdown of academic impact, for papers by Kunihide Ishii
Rankless by CCL
2026